Two cases of gastric cancer with peritoneal carcinomatosis successfully responding to combination chemotherapy of S-1 and cisplatin, leading to clinical complete response

被引:0
|
作者
Suzuki, Shuhei [1 ]
Ito, Yuriko [1 ]
Fukui, Tadahisa [1 ]
Orihara, Mika [1 ]
Nakamura, Sho [1 ]
Takahashi, Masahiro [1 ]
Fujimoto, Hiroto [2 ]
Kimura, Wataru [2 ]
Yoshioka, Takashi [1 ]
机构
[1] Yamagata Univ, Yamagata Fac Med, Dept Clin Oncol, 2-2-2 Iida Nishi, Yamagata 9909585, Japan
[2] Yamagata Univ, Yamagata Fac Med, Dept Surg 1, Yamagata, Japan
来源
INTERNATIONAL CANCER CONFERENCE JOURNAL | 2013年 / 2卷 / 04期
关键词
Gastric cancer; Clinical complete response; Cisplatin; S-1; Chemotherapy;
D O I
10.1007/s13691-013-0090-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We report two cases of gastric cancer with peritoneal carcinomatosis successfully responding to combination chemotherapy of S-1 and cisplatin, leading to a clinical complete response (cCR). In case 1, a 60-year-old woman achieved a cCR after 6 cycles of S-1 and cisplatin. Eight cycles of S-1 and cisplatin and 16 cycles of S-1 alone were administered. Since treatment with S-1 alone, only observation has been performed with no recurrence. In case 2, a 63-year-old man achieved cCR after 2 cycles of S-1 and cisplatin chemotherapy. After 8 cycles of chemotherapy, cCR was confirmed, and a curative operation was performed. After surgery, a small number of viable cells were found in the pathological examination. Fifty-four reports of cCR cases of advanced non-resectable or metastatic gastric cancer with chemotherapy have been published, but none mentioned the treatment options after cCR. In this report, we show two patients choosing different paths after achieving cCR by chemotherapy. In our surgical case, residues of pathologically viable cancer cells were confirmed, so surgery might be recommended after cCR, but further investigation will be needed.
引用
收藏
页码:201 / 205
页数:5
相关论文
共 50 条
  • [1] Two cases of gastric cancer with peritoneal carcinomatosis successfully responding to combination chemotherapy of S-1 and cisplatin, leading to clinical complete response
    Shuhei Suzuki
    Yuriko Ito
    Tadahisa Fukui
    Mika Orihara
    Sho Nakamura
    Masahiro Takahashi
    Hiroto Fujimoto
    Wataru Kimura
    Takashi Yoshioka
    International Cancer Conference Journal, 2013, 2 (4) : 201 - 205
  • [2] Pathological Complete Response by S-1 Chemotherapy in Advanced Gastric Cancer
    Namikawa, Tsutomu
    Ishida, Nobuko
    Tsuda, Sachi
    Fujisawa, Kazune
    Munekage, Eri
    Iwabu, Jun
    Munekage, Masaya
    Uemura, Sunao
    Tsujii, Shigehiro
    Maeda, Hiromichi
    Kitagawa, Hiroyuki
    Kobayashi, Michiya
    Hanazaki, Kazuhiro
    IN VIVO, 2018, 32 (05): : 1211 - 1216
  • [3] Docetaxel, cisplatin and S-1 (DCS) combination chemotherapy for gastric cancer patients with peritoneal metastasis: a retrospective study
    Ohnuma, Hiroyuki
    Sato, Yasushi
    Hirakawa, Masahiro
    Kikuchi, Shohei
    Miyanishi, Koji
    Sagawa, Tamotsu
    Takahashi, Yasuo
    Nobuoka, Takayuki
    Okamoto, Koichi
    Miyamoto, Hiroshi
    Takemasa, Ichiro
    Takayama, Tetsuji
    Kato, Junji
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (03) : 539 - 548
  • [4] Docetaxel, cisplatin and S-1 (DCS) combination chemotherapy for gastric cancer patients with peritoneal metastasis: a retrospective study
    Hiroyuki Ohnuma
    Yasushi Sato
    Masahiro Hirakawa
    Shohei Kikuchi
    Koji Miyanishi
    Tamotsu Sagawa
    Yasuo Takahashi
    Takayuki Nobuoka
    Koichi Okamoto
    Hiroshi Miyamoto
    Ichiro Takemasa
    Tetsuji Takayama
    Junji Kato
    Cancer Chemotherapy and Pharmacology, 2018, 81 : 539 - 548
  • [5] Feasibility and Efficacy of Combination Chemotherapy with S-1 and Fractional Cisplatin for Advanced Gastric Cancer
    Takahashi, Tsunehiro
    Saikawa, Yoshiro
    Takaishi, Hiromasa
    Takeuchi, Hiroya
    Wada, Norihito
    Oyama, Takashi
    Nakamura, Rieko
    Kitagawa, Yuko
    ANTICANCER RESEARCH, 2010, 30 (09) : 3759 - 3762
  • [6] Efficacy and Feasibility of Combination Chemotherapy with S-1 and Cisplatin (2 Weeks Regimen) for Advanced Gastric Cancer
    Abe, Seiichiro
    Tsuji, Yasushi
    Tsushima, Takahiro
    Kogawa, Takahiro
    Abe, Masakazu
    Onodera, Yoshimitsu
    Mizushima, Takeshi
    Kukitsu, Takehiro
    Sumiyoshi, Tetsuya
    Yoshizaki, Naohito
    Ishii, Toru
    Kondo, Hitoshi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (04) : 302 - 306
  • [7] Phase II study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer
    Sato, Yasushi
    Takayama, Tetsuji
    Sagawa, Tamotsu
    Takahashi, Yasuo
    Ohnuma, Hiroyuki
    Okubo, Syunichi
    Shintani, Naoaki
    Tanaka, Shingo
    Kida, Masaya
    Sato, Yasuhiro
    Ohta, Hidetoshi
    Miyanishi, Koji
    Sato, Tsutomu
    Takimoto, Rishu
    Kobune, Masayoshi
    Yamaguchi, Koji
    Hirata, Koichi
    Niitsu, Yoshiro
    Kato, Junji
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (04) : 721 - 728
  • [8] S-1 combined with cisplatin chemotherapy for advanced gastric cancer
    Chen Weidong
    Xia Lijun
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2016, 12 (05) : 54 - 56
  • [9] Phase II study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer
    Yasushi Sato
    Tetsuji Takayama
    Tamotsu Sagawa
    Yasuo Takahashi
    Hiroyuki Ohnuma
    Syunichi Okubo
    Naoaki Shintani
    Shingo Tanaka
    Masaya Kida
    Yasuhiro Sato
    Hidetoshi Ohta
    Koji Miyanishi
    Tsutomu Sato
    Rishu Takimoto
    Masayoshi Kobune
    Koji Yamaguchi
    Koichi Hirata
    Yoshiro Niitsu
    Junji Kato
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 721 - 728
  • [10] Complete response of highly advanced gastric cancer with peritoneal dissemination after new combined chemotherapy of S-1 and low-dose cisplatin: Report of a case
    Iwahashi, M
    Nakamori, M
    Tani, M
    Yamaue, H
    Sakaguchi, S
    Nakamura, M
    Ueda, K
    Ichiro, M
    Nishino, E
    Tanimura, H
    ONCOLOGY, 2001, 61 (01) : 16 - 22